More articles from Special Section on Transporters in Drug Disposition and Pharmacokinetic Prediction

Open Access
A Clinical Quantitative Evaluation of Hepatobiliary Transport of [¹¹C]Dehydropravastatin in Humans Using Positron Emission Tomography
Ken-ichi Kaneko, Masaaki Tanaka, Akira Ishii, Yumiko Katayama, Takayoshi Nakaoka, Satsuki Irie, Hideki Kawahata, Takashi Yamanaga, Yasuhiro Wada, Takeshi Miyake, Kota Toshimoto, Kazuya Maeda, Yilong Cui, Masaru Enomoto, Etsushi Kawamura, Norifumi Kawada, Joji Kawabe, Susumu Shiomi, Hiroyuki Kusuhara, Yuichi Sugiyama and Yasuyoshi Watanabe

Drug Metabolism and Disposition May 2018, 46 (5) 719-728; DOI: https://doi.org/10.1124/dmd.118.080408
You have access
Brain Distribution of a Novel MEK Inhibitor E6201: Implications in the Treatment of Melanoma Brain Metastases
Gautham Gampa, Minjee Kim, Nicholas Cook-Rostie, Janice K. Laramy, Jann N. Sarkaria, Linda Paradiso, Louis DePalatis and William F. Elmquist

Drug Metabolism and Disposition May 2018, 46 (5) 658-666; DOI: https://doi.org/10.1124/dmd.117.079194
You have access
Identification of a NFκB Inhibition Site on the Proximal Promoter Region of Human Organic Anion Transporting Polypeptide 1A2 Coding Gene SLCO1A2
Zhaojian Xiang, Weike Li, Lixue Wang, Jicai Yi, Kaiwen Chen and Mei Hong

Drug Metabolism and Disposition May 2018, 46 (5) 643-651; DOI: https://doi.org/10.1124/dmd.117.078832
You have access
Curcumin as an In Vivo Selective Intestinal Breast Cancer Resistance Protein Inhibitor in Cynomolgus Monkeys
Tsuyoshi Karibe, Tomoki Imaoka, Koji Abe and Osamu Ando

Drug Metabolism and Disposition May 2018, 46 (5) 667-679; DOI: https://doi.org/10.1124/dmd.117.078931
You have access
Organic Anion Transporting Polypeptide 1a4 is Responsible for the Hepatic Uptake of Cardiac Glycosides in Mice
Junichi Takano, Kazuya Maeda, Hiroyuki Kusuhara and Yuichi Sugiyama

Drug Metabolism and Disposition May 2018, 46 (5) 652-657; DOI: https://doi.org/10.1124/dmd.117.079483
You have access
Intravital Multiphoton Microscopy with Fluorescent Bile Salts in Rats as an In Vivo Biomarker for Hepatobiliary Transport Inhibition
Jennifer Ryan, Ryan E. Morgan, Yuan Chen, Laurie P. Volak, Robert T. Dunn and Kenneth W. Dunn

Drug Metabolism and Disposition May 2018, 46 (5) 704-718; DOI: https://doi.org/10.1124/dmd.117.079277
You have access
Evaluation of Alteration in Hepatic and Intestinal BCRP Function In Vivo from ABCG2 c.421C>A Polymorphism Based on PBPK Analysis of Rosuvastatin
Azusa Futatsugi, Kota Toshimoto, Takashi Yoshikado, Yuichi Sugiyama and Yukio Kato

Drug Metabolism and Disposition May 2018, 46 (5) 749-757; DOI: https://doi.org/10.1124/dmd.117.078816
You have access
Rare Variants in the ABCG2 Promoter Modulate In Vivo Activity
Rachel J. Eclov, Mee J. Kim, Robin Smith, Nadav Ahituv and Deanna L. Kroetz

Drug Metabolism and Disposition May 2018, 46 (5) 636-642; DOI: https://doi.org/10.1124/dmd.117.079541
You have access
Prediction of the Effects of Renal Impairment on Clearance for Organic Cation Drugs that Undergo Renal Secretion: A Simulation-Based Study
Kristin E. Follman and Marilyn E. Morris

Drug Metabolism and Disposition May 2018, 46 (5) 758-769; DOI: https://doi.org/10.1124/dmd.117.079558
You have access
Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction
Qingcheng Mao, Yurong Lai and Joanne Wang

Drug Metabolism and Disposition May 2018, 46 (5) 561-566; DOI: https://doi.org/10.1124/dmd.118.081356

Main menu

User menu

Search

More articles from Special Section on Transporters in Drug Disposition and Pharmacokinetic Prediction

Pages

Navigate

More Information

ASPET's Other Journals